Niwa T - Search Results

1

Heterotropic cooperativity in oxidation mediated by cytochrome p450.

Niwa T, Murayama N, Yamazaki H. Niwa T, et al. Curr Drug Metab. 2008 Jun;9(5):453-62. doi: 10.2174/138920008784746364. Curr Drug Metab. 2008. PMID: 18537580 Review.

2

Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5.

Niwa T, Murayama N, Emoto C, Yamazaki H. Niwa T, et al. Curr Drug Metab. 2008 Jan;9(1):20-33. doi: 10.2174/138920008783331121. Curr Drug Metab. 2008. PMID: 18220568 Review.

3

Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.

Niwa T, Murayama N, Yamazaki H. Niwa T, et al. Curr Drug Metab. 2009 Sep;10(7):700-12. doi: 10.2174/138920009789895525. Curr Drug Metab. 2009. PMID: 19594405 Review.

4

Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.

Yamazaki H, Nakamoto M, Shimizu M, Murayama N, Niwa T. Yamazaki H, et al. Among authors: niwa t. Br J Clin Pharmacol. 2010 Jun;69(6):593-7. doi: 10.1111/j.1365-2125.2010.03656.x. Br J Clin Pharmacol. 2010. PMID: 20565450 Free PMC article.

5

Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition.

Niwa T, Murayama N, Yamazaki H. Niwa T, et al. Curr Drug Metab. 2011 Jun;12(5):412-35. doi: 10.2174/138920011795495286. Curr Drug Metab. 2011. PMID: 21453270 Review.

6

Stereoselectivity of human cytochrome p450 in metabolic and inhibitory activities.

Niwa T, Murayama N, Yamazaki H. Niwa T, et al. Curr Drug Metab. 2011 Jul;12(6):549-69. doi: 10.2174/138920011795713724. Curr Drug Metab. 2011. PMID: 21476971 Review.

7

Human liver enzymes responsible for metabolic elimination of tyramine; a vasopressor agent from daily food.

Niwa T, Murayama N, Umeyama H, Shimizu M, Yamazaki H. Niwa T, et al. Drug Metab Lett. 2011 Aug;5(3):216-9. doi: 10.2174/187231211796905026. Drug Metab Lett. 2011. PMID: 21679153

8

Comparison of cytochrome P450 2C subfamily members in terms of drug oxidation rates and substrate inhibition.

Niwa T, Yamazaki H. Niwa T, et al. Curr Drug Metab. 2012 Oct;13(8):1145-59. doi: 10.2174/138920012802850092. Curr Drug Metab. 2012. PMID: 22571484 Review.

9

Comparison of catalytic properties of cytochromes P450 3A4 and 3A5 by molecular docking simulation.

Niwa T, Yasumura M, Murayama N, Yamazaki H. Niwa T, et al. Drug Metab Lett. 2014;8(1):43-50. doi: 10.2174/1872312807666131229121228. Drug Metab Lett. 2014. PMID: 24484539

10

Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450.

Niwa T, Imagawa Y, Yamazaki H. Niwa T, et al. Curr Drug Metab. 2014;15(7):651-79. doi: 10.2174/1389200215666141125121511. Curr Drug Metab. 2014. PMID: 25429674 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,136 results

Search Page

Filters